RAN overexpression was remarkably linked to poor overall survival (OS), relapse-free survival (RFS), progression-free survival (PFS), and disease-specific survival (DSS) in HCC patients (Figure 6a–d). The gene discussed is RAN; the disease is hepatocellular carcinoma.